Jazz Pharmaceuticals JAZZ Property, plant and equipment, net
Property, plant and equipment, net at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's property, plant and equipment, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's property, plant and equipment, net?
- Jazz Pharmaceuticals (JAZZ) reported property, plant and equipment, net of $203.1M in Q1 2026.
- How has Jazz Pharmaceuticals's property, plant and equipment, net changed year-over-year?
- Jazz Pharmaceuticals's property, plant and equipment, net increased by 13.5% year-over-year, from $178.87M to $203.1M.
- What is the long-term trend for Jazz Pharmaceuticals's property, plant and equipment, net?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's property, plant and equipment, net has grown at a 9.3% compound annual growth rate (CAGR), from $127.94M to $199.9M.